MindWalk Holdings (HYFT) EBITDA (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly EBITDA came in at -$2.3 million in Q2 2026, down 95.61% year-over-year from -$53.0 million in Q2 2025, and up 12.04% quarter-over-quarter from -$2.6 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) EBITDA (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBITDA for 7 consecutive years, with -$2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 95.61% year-over-year to -$2.3 million in Q2 2026; TTM through Apr 2026 was -$10.0 million, a 99.72% increase from a year earlier, with the FY2026 full-year figure at -$10.8 million, down 165.05% from the prior year.
- EBITDA was -$2.3 million for Q2 2026 at MindWalk Holdings, up from -$2.6 million in the prior quarter.
- Over five years, EBITDA peaked at -$1.2 million in Q2 2025 and troughed at -$5.1 billion in Q3 2023.
- A 5-year average of -$723.3 million and a median of -$3.4 million in 2022 frame the typical range for EBITDA.
- Across the five-year window, EBITDA plunged 72164.45% in 2023 and jumped 99.93% in 2024, its largest moves.
- Over 5 years, EBITDA stood at -$5.9 million in 2022, then sank by 72164.45% to -$4.3 billion in 2023, then jumped by 99.93% to -$3.0 million in 2024, then jumped by 32.62% to -$2.0 million in 2025, then decreased by 16.4% to -$2.3 million in 2026.
- The last three EBITDA figures came in at -$2.3 million (Q2 2026), -$2.6 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.09 Bn | 41.14 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 16.40 Bn | 15.90 Bn | 201.64 Mn | 153.38 Mn |
| 3 | Charles River Laboratories International | 13.28 Bn | 13.13 Bn | 452.07 Mn | 119.89 Mn |
| 4 | Icon | 12.96 Bn | 12.04 Bn | 479.29 Mn | 327.25 Mn |
| 5 | Fortrea Holdings | 1.64 Bn | 1.47 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 615.12 Mn | 189.24 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 430.05 Mn | 345.51 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 70.57 Mn | 66.73 Mn | 7.70 Mn | -409,000.00 |
| 9 | MindWalk Holdings | 60.73 Mn | 52.45 Mn | 1.82 Mn | -2.33 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -2.33 Mn |
| Jan 31, 2026 | -2.65 Mn |
| Oct 31, 2025 | -2.00 Mn |
| Jul 31, 2025 | -3.03 Mn |
| Apr 30, 2025 | -1.19 Mn |
| Jan 31, 2025 | -17.51 Mn |
| Oct 31, 2024 | -2.97 Mn |
| Jul 31, 2024 | -3.56 Bn |
| Apr 30, 2024 | -16.47 Mn |
| Jan 31, 2024 | -2.47 Mn |
| Oct 31, 2023 | -4.26 Bn |
| Jul 31, 2023 | -5.13 Bn |
| Apr 30, 2023 | -4.49 Mn |
| Jan 31, 2023 | -3.40 Mn |
| Oct 31, 2022 | -5.89 Mn |
| Jul 31, 2022 | -7.81 Mn |
| Apr 30, 2022 | -3.38 Mn |
| Jan 31, 2022 | -2.63 Mn |
| Oct 31, 2021 | -3.56 Mn |
| Jul 31, 2021 | -2.82 Mn |